
Glycebose 0.3mg Tablet
Marketer
Cognitive Life Sciences Ltd
Salt Composition
Voglibose (0.3mg)
Overview Glycebose 0.3mg Tablet
Miglitol 0.3mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated blood glucose following meals, particularly when dietary changes and other comparable medications prove insufficient. Administer this tablet immediately prior to eating; dosage and frequency should be determined by your physician to optimize blood sugar control. Discontinue use only under medical supervision, as abrupt cessation may lead to dangerously high blood sugar, risking severe complications such as renal impairment and vision loss. Treatment involves a comprehensive approach encompassing diet, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Common adverse effects may include gas, abdominal discomfort, appetite suppression, constipation, and diarrhea. Report persistent or troublesome side effects to your physician. While this medication itself doesn't induce hypoglycemia, combining it with other diabetes treatments (especially insulin or sulfonylureas) may cause low blood sugar. If hypoglycemia occurs, treat it with plain glucose; ordinary table sugar is ineffective in this context. Inform your doctor of any liver or kidney issues before commencing treatment. Avoid use if you have bowel inflammation or ulceration (like Crohn's disease or ulcerative colitis). Pregnant or breastfeeding individuals should seek medical advice prior to use. Always disclose all other medications you're taking to ensure medication safety. Limit alcohol consumption while using this medicine to reduce the hypoglycemia risk.
Primary Ingredients of Glycebose 0.3mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Glycebose 0.3mg Tablet
Managing Type 2 diabetes
Major Benefits of Glycebose 0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glycebose 0.3mg Tablet should be taken on an empty stomach.
Common Side effects of Glycebose 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Glycebose 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 0.3mg Glycebose tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Glycebose 0.3mg Tablet works:
Glycebose 0.3mg tablets are used to manage diabetes. Their mechanism involves blocking intestinal enzymes that digest complex carbohydrates, thereby reducing postprandial glucose spikes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glycebose 0.3mg Tablet is contraindicated.
PregnancySAFE IF PRESCRIBED
The use of 0.3mg Glycebose tablets during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The use of 0.3mg Glycebose tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Glycebose 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Glycebose 0.3mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using 0.3mg Glycebose tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Glycebose 0.3mg Tablet :
Omit any missed Glycebose 0.3mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glycebose 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Alpha-glucosidase inhibitors |
